USANA Health Sciences Company Profile (NYSE:USNA)

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences logoUSANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Personal Products
  • Sub-Industry: Personal Products
  • Symbol: NYSE:USNA
  • CUSIP: 90328M10
  • Web:
  • Market Cap: $1.38236 billion
  • Outstanding Shares: 24,445,000
Average Prices:
  • 50 Day Moving Avg: $57.65
  • 200 Day Moving Avg: $60.18
  • 52 Week Range: $52.55 - $75.00
  • Trailing P/E Ratio: 14.69
  • Foreward P/E Ratio: Infinity
  • P/E Growth: 1.47
Sales & Book Value:
  • Annual Revenue: $1.02 billion
  • Price / Sales: 1.36
  • Book Value: $15.56 per share
  • Price / Book: 3.63
  • EBIDTA: $147.32 million
  • Net Margins: 9.47%
  • Return on Equity: 28.93%
  • Return on Assets: 20.74%
  • Current Ratio: 2.44%
  • Quick Ratio: 1.93%
  • Average Volume: 129,117 shs.
  • Beta: 1.1
  • Short Ratio: 8.18

Frequently Asked Questions for USANA Health Sciences (NYSE:USNA)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences declared that its board has initiated a stock buyback program on Wednesday, July 26th 2017, which allows the company to buyback $64,600,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 46% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's management believes its stock is undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $0.98 earnings per share for the quarter, missing analysts' consensus estimates of $1.06 by $0.08. The company earned $257.10 million during the quarter, compared to analysts' expectations of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The firm's revenue for the quarter was down .5% on a year-over-year basis. During the same period in the previous year, the firm posted $2.07 EPS. View USANA Health Sciences' Earnings History.

When will USANA Health Sciences make its next earnings announcement?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $3.50-3.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.06. The company issued revenue guidance of $1.02-1.03 billion, compared to the consensus revenue estimate of $1.07 billion.

Where is USANA Health Sciences' stock going? Where will USANA Health Sciences' stock price be in 2017?

1 analysts have issued 1-year price targets for USANA Health Sciences' shares. Their predictions range from $70.00 to $70.00. On average, they anticipate USANA Health Sciences' share price to reach $70.00 in the next twelve months. View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:

  • Myron W. Wentz Ph.D., Chairman, Independent Director
  • Jim Brown, President, Chief Operating Officer
  • Kevin G. Guest, Chief Executive Officer, Independent Director
  • G. Douglas Hekking, Chief Financial Officer
  • Josh Foukas, Executive Vice President - Legal
  • Brent Neidig, Executive Vice President - China
  • Walter Noot, Chief Information Officer
  • Douglas Braun, Chief Marketing Officer
  • Robert A. Sinnott Ph.D, Chief Scientific Officer
  • James H. Bramble, Chief Legal Officer and Corporate Secretary

Who owns USANA Health Sciences stock?

USANA Health Sciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (7.79%), FMR LLC (6.39%), Vanguard Group Inc. (3.92%), Dimensional Fund Advisors LP (2.84%), Schroder Investment Management Group (2.29%) and Nordea Investment Management AB (1.34%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, Dave Wentz, Deborah Woo, Doug Braun, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jerry G Mcclain, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Rick Stambaugh and Robert Auciaux. View Institutional Ownership Trends for USANA Health Sciences.

Who sold USANA Health Sciences stock? Who is selling USANA Health Sciences stock?

USANA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Citadel Advisors LLC, Menta Capital LLC, Prudential Financial Inc., Spark Investment Management LLC, Tudor Investment Corp ET AL, Acadian Asset Management LLC and Citigroup Inc.. Company insiders that have sold USANA Health Sciences stock in the last year include Daniel A Macuga, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz and Paul A Jones. View Insider Buying and Selling for USANA Health Sciences.

Who bought USANA Health Sciences stock? Who is buying USANA Health Sciences stock?

USANA Health Sciences' stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, FMR LLC, Old Mutual Global Investors UK Ltd., Schroder Investment Management Group, TIAA CREF Investment Management LLC, Vanguard Group Inc. and GSA Capital Partners LLP. View Insider Buying and Selling for USANA Health Sciences.

How do I buy USANA Health Sciences stock?

Shares of USANA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USANA Health Sciences stock can currently be purchased for approximately $56.55.

MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  258
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for USANA Health Sciences (NYSE:USNA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $70.00 (23.78% upside)

Analysts' Ratings History for USANA Health Sciences (NYSE:USNA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/26/2017Pivotal ResearchLower Price TargetBuy -> Buy$75.00 -> $70.00HighView Rating Details
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 -> $150.00N/AView Rating Details
11/4/2015Canaccord GenuityReiterated RatingHold$131.00N/AView Rating Details
10/16/2015SidotiUpgradeNeutral -> Buy$156.00N/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for USANA Health Sciences (NYSE:USNA)
Earnings by Quarter for USANA Health Sciences (NYSE:USNA)
Earnings History by Quarter for USANA Health Sciences (NYSE USNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017N/AView Earnings Details
7/25/2017Q2 2017$1.06$0.98$273.61 million$257.10 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.92$0.91$255.32 millionViewListenView Earnings Details
2/7/2017Q416$0.94$0.87$253.52 million$252.90 millionViewListenView Earnings Details
10/25/2016Q316$2.13$2.40$263.37 million$254.22 millionViewListenView Earnings Details
7/26/2016Q2$2.05$2.07$256.66 million$258.50 millionViewListenView Earnings Details
5/3/2016Q116$1.81$1.77$244.05 million$240.45 millionViewListenView Earnings Details
2/9/2016Q415$2.00$1.83$250.82 million$232.60 millionViewListenView Earnings Details
11/3/2015Q315$1.76$1.92$230.79 million$233.30 millionViewListenView Earnings Details
8/4/2015Q215$1.60$1.92$211.86 million$233.20 millionViewListenView Earnings Details
5/5/2015Q1$1.30$1.50$198.21 million$219.40 millionViewListenView Earnings Details
2/10/2015Q414$1.93$1.65$219.10 million$227.90 millionViewListenView Earnings Details
10/28/2014Q314$1.37$1.47$190.50 million$191.90 millionViewListenView Earnings Details
7/29/2014Q214$1.50$1.36$198.30 million$188.30 millionViewListenView Earnings Details
4/29/2014Q114$1.30$1.15$185.85 million$182.40 millionViewListenView Earnings Details
2/5/2014Q413$1.22$1.41$175.53 million$186.30 millionViewListenView Earnings Details
10/23/2013Q313$1.14$1.16$172.40 million$173.70 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.33$1.72$176.60 million$189.10 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.16$1.28$171.77 million$169.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$1.21$1.27$165.80 million$168.50 millionViewListenView Earnings Details
10/23/2012$1.06$1.18ViewN/AView Earnings Details
7/24/2012$0.92$1.11ViewN/AView Earnings Details
2/7/2012$0.86$0.87ViewN/AView Earnings Details
10/25/2011$0.76$0.81ViewN/AView Earnings Details
4/26/2011$0.66$0.70ViewN/AView Earnings Details
2/8/2011$0.84$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for USANA Health Sciences (NYSE:USNA)
Current Year EPS Consensus Estimate: $3.6 EPS


Dividend History for USANA Health Sciences (NYSE:USNA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for USANA Health Sciences (NYSE:USNA)
Insider Ownership Percentage: 53.20%
Institutional Ownership Percentage: 44.87%
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017Myron W WentzDirectorSell28,788$57.19$1,646,385.72View SEC Filing  
9/14/2017Global Ltd GullMajor ShareholderSell79,294$57.61$4,568,127.34View SEC Filing  
9/14/2017Myron W WentzDirectorSell34,226$57.51$1,968,337.26View SEC Filing  
9/5/2017Global Ltd GullMajor ShareholderSell40,000$58.41$2,336,400.00View SEC Filing  
8/30/2017Daniel A MacugaInsiderSell11,992$59.00$707,528.00View SEC Filing  
8/28/2017Daniel A MacugaInsiderSell5,751$60.00$345,060.00View SEC Filing  
8/23/2017Jim BrownCOOSell16,574$58.84$975,214.16View SEC Filing  
8/23/2017Kevin GuestInsiderSell29,934$59.01$1,766,405.34View SEC Filing  
8/21/2017James BrambleInsiderSell18,298$57.01$1,043,168.98View SEC Filing  
8/2/2017Global Ltd GullMajor ShareholderSell14,533$56.71$824,166.43View SEC Filing  
8/2/2017Myron W WentzDirectorSell40,000$56.59$2,263,600.00View SEC Filing  
8/1/2017Global Ltd GullMajor ShareholderSell25,467$56.52$1,439,394.84View SEC Filing  
7/31/2017Gilbert A FullerDirectorSell1,483$57.67$85,524.61View SEC Filing  
7/5/2017Myron W WentzDirectorSell40,000$64.15$2,566,000.00View SEC Filing  
6/2/2017Myron W WentzDirectorSell40,000$64.99$2,599,600.00View SEC Filing  
6/1/2017Paul A JonesInsiderSell9,851$64.50$635,389.50View SEC Filing  
5/11/2017Gilbert A FullerDirectorSell4,884$64.38$314,431.92View SEC Filing  
5/1/2017Myron W WentzDirectorSell40,000$56.39$2,255,600.00View SEC Filing  
4/5/2017Global Ltd GullMajor ShareholderSell16,436$56.54$929,291.44View SEC Filing  
4/5/2017Myron W WentzDirectorSell40,000$56.81$2,272,400.00View SEC Filing  
4/4/2017Global Ltd GullMajor ShareholderSell10,040$56.69$569,167.60View SEC Filing  
4/3/2017Global Ltd GullMajor ShareholderSell13,524$57.22$773,843.28View SEC Filing  
3/8/2017Global Ltd GullMajor ShareholderSell20,000$57.15$1,143,000.00View SEC Filing  
2/8/2017Global Ltd GullMajor ShareholderSell20,000$55.87$1,117,400.00View SEC Filing  
1/11/2017Myron W WentzDirectorSell20,000$61.04$1,220,800.00View SEC Filing  
12/14/2016Myron W WentzDirectorSell20,000$61.41$1,228,200.00View SEC Filing  
11/9/2016Myron W WentzDirectorSell10,000$123.99$1,239,900.00View SEC Filing  
10/12/2016Global Ltd GullMajor ShareholderSell10,000$146.35$1,463,500.00View SEC Filing  
9/14/2016Global Ltd GullMajor ShareholderSell10,000$134.67$1,346,700.00View SEC Filing  
9/8/2016Deborah WooInsiderSell1,058$140.00$148,120.00View SEC Filing  
8/30/2016Paul A JonesCFOSell5,067$138.50$701,779.50View SEC Filing  
8/23/2016Deborah WooInsiderSell2,621$138.94$364,161.74View SEC Filing  
8/23/2016Robert AuciauxDirectorSell2,317$138.79$321,576.43View SEC Filing  
8/19/2016Deborah WooInsiderSell4,590$133.12$611,020.80View SEC Filing  
8/18/2016Deborah WooInsiderSell5,041$131.15$661,127.15View SEC Filing  
8/16/2016James BrambleInsiderSell9,339$131.33$1,226,490.87View SEC Filing  
8/16/2016Jim BrownCOOSell9,104$131.36$1,195,901.44View SEC Filing  
8/15/2016Kevin GuestInsiderSell16,285$131.08$2,134,637.80View SEC Filing  
8/10/2016Global Ltd GullMajor ShareholderSell10,000$135.08$1,350,800.00View SEC Filing  
8/1/2016Gilbert A. FullerDirectorSell859$137.07$117,743.13View SEC Filing  
7/13/2016Global Ltd GullMajor ShareholderSell10,000$118.96$1,189,600.00View SEC Filing  
6/8/2016Global Ltd GullMajor ShareholderSell10,000$123.47$1,234,700.00View SEC Filing  
6/7/2016Dave WentzInsiderSell10,000$125.09$1,250,900.00View SEC Filing  
5/11/2016Global Ltd GullMajor ShareholderSell10,000$122.67$1,226,700.00View SEC Filing  
4/13/2016Global Ltd GullMajor ShareholderSell10,000$121.82$1,218,200.00View SEC Filing  
3/9/2016Myron W WentzDirectorSell10,000$116.07$1,160,700.00View SEC Filing  
3/4/2016Jerry G McclainDirectorSell767$118.17$90,636.39View SEC Filing  
2/24/2016Gilbert A FullerDirectorSell728$113.22$82,424.16View SEC Filing  
2/10/2016Global Ltd GullMajor ShareholderSell10,000$96.37$963,700.00View SEC Filing  
1/13/2016Global Ltd GullMajor ShareholderSell10,000$121.04$1,210,400.00View SEC Filing  
12/17/2015Rick StambaughinsiderSell7,059$130.18$918,940.62View SEC Filing  
12/16/2015Doug BraunCMOSell10,907$130.80$1,426,635.60View SEC Filing  
12/15/2015Dave WentzInsiderSell6,000$130.59$783,540.00View SEC Filing  
12/15/2015Doug BraunCMOSell2,748$132.00$362,736.00View SEC Filing  
12/9/2015Myron W WentzDirectorSell10,000$133.18$1,331,800.00View SEC Filing  
11/11/2015Global Ltd GullMajor ShareholderSell10,000$133.71$1,337,100.00View SEC Filing  
10/1/2015Myron W WentzDirectorSell10,000$131.85$1,318,500.00View SEC Filing  
9/10/2015Myron W WentzDirectorSell7,000$138.32$968,240.00View SEC Filing  
8/27/2015Deborah WooinsiderSell1,527$150.00$229,050.00View SEC Filing  
8/17/2015Paul A JonesCFOSell7,719$162.21$1,252,098.99View SEC Filing  
8/12/2015Myron W WentzDirectorSell7,000$159.84$1,118,880.00View SEC Filing  
7/8/2015Myron W WentzDirectorSell7,000$138.28$967,960.00View SEC Filing  
6/10/2015Myron W WentzDirectorSell7,000$133.75$936,250.00View SEC Filing  
6/9/2015Deborah WooInsiderSell3,656$132.06$482,811.36View SEC Filing  
5/14/2015Deborah WooInsiderSell3,569$124.00$442,556.00View SEC Filing  
5/12/2015Kevin GuestInsiderSell2,858$120.00$342,960.00View SEC Filing  
5/11/2015Daniel A MacugaInsiderSell4,231$125.64$531,582.84View SEC Filing  
5/11/2015Jim BrownCOOSell7,860$124.46$978,255.60View SEC Filing  
4/8/2015Global Ltd GullMajor ShareholderSell7,000$113.54$794,780.00View SEC Filing  
2/12/2015Robert AuciauxDirectorSell5,028$100.18$503,705.04View SEC Filing  
1/14/2015Myron W WentzDirectorSell7,000$101.32$709,240.00View SEC Filing  
12/16/2014Doug BraunCMOSell9,969$101.01$1,006,968.69View SEC Filing  
12/10/2014Myron W WentzDirectorSell102,755$100.25$10,301,188.75View SEC Filing  
12/8/2014Myron W WentzDirectorSell184,245$104.65$19,281,239.25View SEC Filing  
11/3/2014Dave WentzInsiderSell19,780$114.68$2,268,370.40View SEC Filing  
10/31/2014Ronald S PoelmanDirectorSell4,491$112.53$505,372.23View SEC Filing  
10/30/2014Paul A JonesCFOSell10,823$105.10$1,137,497.30View SEC Filing  
10/8/2014Myron W WentzDirectorSell7,000$76.52$535,640.00View SEC Filing  
9/10/2014Myron W WentzDirectorSell7,000$71.53$500,710.00View SEC Filing  
8/25/2014Dave WentzInsiderSell5,141$73.30$376,835.30View SEC Filing  
7/9/2014Myron W WentzDirectorSell7,000$78.95$552,650.00View SEC Filing  
6/13/2014Dave WentzInsiderSell5,301$75.51$400,278.51View SEC Filing  
6/11/2014Myron W WentzDirectorSell7,000$74.69$522,830.00View SEC Filing  
6/10/2014Daniel A MacugaInsiderSell6,654$75.01$499,116.54View SEC Filing  
5/30/2014Deborah WooInsiderSell1,028$73.00$75,044.00View SEC Filing  
5/28/2014Dave WentzInsiderSell5,141$73.03$375,447.23View SEC Filing  
5/28/2014Jerry G McclainDirectorSell1,217$72.12$87,770.04View SEC Filing  
5/22/2014Kevin GuestInsiderSell10,160$71.15$722,884.00View SEC Filing  
5/21/2014Kevin GuestInsiderSell2,475$71.00$175,725.00View SEC Filing  
5/19/2014James BrambleInsiderSell5,919$70.02$414,448.38View SEC Filing  
5/14/2014Myron WentzDirectorSell14,000$73.78$1,032,920.00View SEC Filing  
5/12/2014Deborah WooInsiderSell11,336$70.03$793,860.08View SEC Filing  
5/5/2014Deborah WooInsiderSell3,512$71.00$249,352.00View SEC Filing  
3/4/2014Myron WentzDirectorSell63,805$72.69$4,637,985.45View SEC Filing  
2/11/2014Doug BraunCMOSell8,139$70.46$573,473.94View SEC Filing  
11/13/2013Myron WentzDirectorSell7,000$67.68$473,760.00View SEC Filing  
10/9/2013Holdings Ltd Gullmajor shareholderSell7,000$80.08$560,560.00View SEC Filing  
9/11/2013Deborah WooInsiderSell1,340$79.01$105,873.40View SEC Filing  
9/11/2013Holdings Ltd Gullmajor shareholderSell7,000$78.19$547,330.00View SEC Filing  
9/5/2013Dave WentzInsiderSell13,704$77.93$1,067,952.72View SEC Filing  
9/3/2013Dave WentzInsiderSell32,174$78.10$2,512,789.40View SEC Filing  
8/14/2013Holdings Ltd Gullmajor shareholderSell7,000$80.34$562,380.00View SEC Filing  
8/1/2013Deborah WooInsiderSell1,386$85.00$117,810.00View SEC Filing  
7/26/2013Paul A JonesCFOSell5,047$78.01$393,716.47View SEC Filing  
7/25/2013Kevin GuestInsiderSell19,290$73.20$1,412,028.00View SEC Filing  
7/25/2013Ronald S PoelmanDirectorSell6,380$73.20$467,016.00View SEC Filing  
7/10/2013Holdings Ltd GullMajor ShareholderSell7,000$78.22$547,540.00View SEC Filing  
6/12/2013Holdings Ltd GullMajor ShareholderSell7,000$70.96$496,720.00View SEC Filing  
5/9/2013Robert AuciauxDirectorSell2,664$55.92$148,970.88View SEC Filing  
5/8/2013Holdings Ltd GullMajor ShareholderSell7,000$56.59$396,130.00View SEC Filing  
4/10/2013Holdings Ltd GullMajor ShareholderSell7,000$47.45$332,150.00View SEC Filing  
8/8/2012Myron W WentzDirectorSell7,000$44.21$309,470.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for USANA Health Sciences (NYSE:USNA)
Latest Headlines for USANA Health Sciences (NYSE:USNA)
DateHeadline logoUSANA Health Sciences, Inc. (USNA) Downgraded to "Strong Sell" at BidaskClub - September 22 at 1:22 PM logoUSANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,788 Shares - September 15 at 7:24 PM logoUSANA Health Sciences, Inc. (USNA) Director Sells $1,968,337.26 in Stock - September 15 at 7:24 PM logoUSANA Health Sciences, Inc. (USNA) Major Shareholder Sells $4,568,127.34 in Stock - September 14 at 10:34 PM logoETFs with exposure to USANA Health Sciences, Inc. : September 14, 2017 - September 14 at 1:22 AM logoUSANA Stands Committed to Ethical Business Practices - September 12 at 11:43 AM logoYou Are What You Eat (And Drink) - September 7 at 10:41 AM logoUSANA Health Sciences, Inc. (USNA) Major Shareholder Sells $2,336,400.00 in Stock - September 6 at 7:40 PM logoUSANA True Health Foundation Donates $130,000 To Victims Of Hurricane Harvey - September 1 at 10:29 AM logoUSANA Health Sciences, Inc. (USNA) Insider Daniel A. Macuga Sells 11,992 Shares - August 30 at 7:34 PM logoUSANA Makes List of Fastest Growing Utah Companies for 10th Consecutive Year - August 30 at 10:40 AM logoUSANA Health Sciences, Inc. (USNA) Insider Daniel A. Macuga Sells 5,751 Shares - August 29 at 7:38 PM logoETFs with exposure to USANA Health Sciences, Inc. : August 25, 2017 - August 25 at 8:24 PM logoJim Brown Sells 16,574 Shares of USANA Health Sciences, Inc. (USNA) Stock - August 23 at 7:46 PM logoInsider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 29,934 Shares of Stock - August 23 at 7:20 PM logoReviewing Colgate-Palmolive (CL) and USANA Health Sciences (USNA) - August 23 at 2:16 PM logoUSANA True Health Foundation Donates Over 1,000,000 Meals To Those In Need - August 23 at 1:20 PM logoFeatured Company News - USANA Announces Plans to Expand In Four European Countries - August 23 at 1:20 PM logoUSANA Announces New Skincare Line - August 23 at 1:20 PM logoJames Bramble Sells 18,298 Shares of USANA Health Sciences, Inc. (USNA) Stock - August 22 at 1:14 PM logoUSANA Health Sciences, Inc. (USNA) Upgraded by BidaskClub to "Sell" - August 22 at 12:44 PM logoUSANA To Expand In Four European Countries Beginning Mid-year 2018 = Quick Facts - Nasdaq - August 19 at 8:43 AM logoUSANA Breaks GUINNESS WORLD RECORDS™ Title at 25th Anniversary Event - August 18 at 8:24 AM logoUSANA Health Sciences, Inc. :USNA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017 - August 18 at 8:24 AM logoUSANA Announces Plans To Expand In Four European Countries - August 18 at 8:24 AM logoMatthews International Corporation (MATW) versus USANA Health Sciences (USNA) Head-To-Head Comparison - August 11 at 2:44 PM logoSee what the IHS Markit Score report has to say about USANA Health Sciences Inc. - August 10 at 3:27 PM logoGlobal Ltd Gull Sells 25,467 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock - August 2 at 7:46 PM logoUSANA Health Sciences, Inc. (USNA) Major Shareholder Sells $824,166.43 in Stock - August 2 at 7:46 PM logoInsider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 40,000 Shares of Stock - August 2 at 7:26 PM logoThe Real USANA Revealed - Seeking Alpha - August 2 at 8:21 AM logoUSANA Joins Forces with Philippines Sports Commission-Philippines Sports Institute - August 2 at 8:21 AM logoBidaskClub Downgrades USANA Health Sciences, Inc. (USNA) to Strong Sell - July 31 at 11:14 PM logoGilbert A. Fuller Sells 1,483 Shares of USANA Health Sciences, Inc. (USNA) Stock - July 31 at 7:44 PM logoReviewing USANA Health Sciences (USNA) and Herbalife LTD. (HLF) - July 29 at 4:24 PM logoUSANA Health Sciences (USNA) & Avon Products (AVP) Head to Head Comparison - July 28 at 4:13 PM logoEdited Transcript of USNA earnings conference call or presentation 26-Jul-17 3:00pm GMT - July 27 at 8:59 AM logoUSANA Health Sciences, Inc. (USNA) Given New $70.00 Price Target at Pivotal Research - July 26 at 7:27 PM logoUSANA Health Sciences (USNA) Board of Directors Approves Stock Repurchase Program - July 26 at 12:01 PM logoPre-Open Stock Movers 07/26: (TTPH) (IRBT) (AMD) Higher; (AMED) (USNA) (DVAX) Lower (more...) - - July 26 at 9:35 AM logoUSANA Health Sciences shares drop after company misses earnings, cuts outlook - MarketWatch - July 26 at 9:35 AM logoUSANA Health Sciences Reports Second Quarter Financial Results - July 26 at 9:35 AM logoUSANA Health Sciences shares drop after company misses earnings, cuts outlook - July 26 at 9:35 AM logoUSANA Health posts 2Q profit - July 26 at 9:35 AM logoUSANA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : USNA-US : July 26, 2017 - July 26 at 9:35 AM logoUSANA Health Sciences, Inc. (NYSE:USNA) Issues Quarterly Earnings Results - July 25 at 10:13 PM logoUSANA Health Sciences, Inc. (NYSE:USNA) Issues FY17 Earnings Guidance - July 25 at 10:12 PM logoReviewing Unilever NV (UN) & USANA Health Sciences (USNA) - July 22 at 4:10 PM logoUSANA Health Sciences, Inc. (USNA) to Release Earnings on Tuesday - July 18 at 8:50 AM logoUSANA Health Sciences, Inc. (NYSE:USNA) Cut to "Sell" at BidaskClub - July 16 at 8:56 PM



USANA Health Sciences (USNA) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by Staff